Loading...

Sema4 Holdings Corp.

SMFRWNASDAQ
Healthcare
Medical - Healthcare Information Services
$0.02
$0.00(0.00%)

Sema4 Holdings Corp. (SMFRW) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Sema4 Holdings Corp. (SMFRW), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
50.79%
50.79%
Operating Income Growth
85.82%
85.82%
Net Income Growth
70.25%
70.25%
Operating Cash Flow Growth
84.18%
84.18%
Operating Margin
1.50%
1.50%
Gross Margin
67.18%
67.18%
Net Profit Margin
0.39%
0.39%
ROE
0.57%
0.57%
ROIC
1.38%
1.38%

Sema4 Holdings Corp. (SMFRW) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Sema4 Holdings Corp. SMFRW financial performance.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$95.64M$76.87M$70.51M$62.42M
Cost of Revenue$29.43M$29.05M$31.97M$29.44M
Gross Profit$66.20M$47.83M$38.54M$32.98M
Gross Profit Ratio$0.69$0.62$0.55$0.53
R&D Expenses$11.59M$11.66M$10.69M$11.37M
SG&A Expenses$45.03M$43.17M$37.31M$33.45M
Operating Expenses$56.61M$54.84M$48.87M$45.80M
Total Costs & Expenses$86.05M$84.65M$80.84M$75.24M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense-$698000.00$843000.00$894000.00$597000.00
Depreciation & Amortization$0.00$5.93M$5.52M$5.65M
EBITDA$8.81M-$1.85M-$22.95M-$14.08M
EBITDA Ratio$0.09-$0.02-$0.07-$0.11
Operating Income$8.81M-$7.78M-$10.33M-$12.82M
Operating Income Ratio$0.09-$0.10-$0.15-$0.21
Other Income/Expenses (Net)-$3.37M-$579000.00-$19.03M-$6.66M
Income Before Tax$5.44M-$8.36M-$29.36M-$20.32M
Income Before Tax Ratio$0.06-$0.11-$0.42-$0.33
Income Tax Expense$0.00-$47000.00-$190000.00-$82000.00
Net Income$5.44M-$8.31M-$29.17M-$20.24M
Net Income Ratio$0.06-$0.11-$0.41-$0.32
EPS$0.20-$0.31-$1.10-$0.78
Diluted EPS$0.20-$0.31-$1.10-$0.78
Weighted Avg Shares Outstanding$26.99M$27.10M$26.62M$26.06M
Weighted Avg Shares Outstanding (Diluted)$26.99M$27.10M$26.62M$26.06M

The company's financials show resilient growth, with revenue advancing from $62.42M in Q1 2024 to $95.64M in Q4 2024. Gross profit remained healthy with margins at 69% in Q4 2024 compared to 53% in Q1 2024. Operating income hit $8.81M last quarter, sustaining a consistent 9% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $8.81M. Net income rose to $5.44M, while earnings per share reached $0.20. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;